Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems. 1985

B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath

Serum prolactin (PRL) level was assessed after challenges with apomorphine hydrochloride, saline, dopamine hydrochloride, or levodopa-carbidopa (Sinemet) in 19 control and 38 chronic schizophrenic subjects. Baseline PRL level varied inversely with age. High correlations existed between baseline PRL level and any subsequent absolute measure of PRL after administration of a dopamine agonist or placebo. Percent decrease was not a function of baseline concentrations and was therefore the only independent measure of drug response. Baseline PRL level was generally lower during exacerbation than remission in patients studied during two states of illness. Percent PRL level decrease after apomorphine administration was significantly greater in normal subjects than in schizophrenics. Correction of apomorphine responses for corresponding placebo (saline) values abolished differences between groups. Prolactin responses after dopamine or levodopa-carbidopa did not differ; however, placebo correction was not possible.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D012107 Research Design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. Experimental Design,Data Adjustment,Data Reporting,Design, Experimental,Designs, Experimental,Error Sources,Experimental Designs,Matched Groups,Methodology, Research,Problem Formulation,Research Methodology,Research Proposal,Research Strategy,Research Technics,Research Techniques,Scoring Methods,Adjustment, Data,Adjustments, Data,Data Adjustments,Design, Research,Designs, Research,Error Source,Formulation, Problem,Formulations, Problem,Group, Matched,Groups, Matched,Matched Group,Method, Scoring,Methods, Scoring,Problem Formulations,Proposal, Research,Proposals, Research,Reporting, Data,Research Designs,Research Proposals,Research Strategies,Research Technic,Research Technique,Scoring Method,Source, Error,Sources, Error,Strategies, Research,Strategy, Research,Technic, Research,Technics, Research,Technique, Research,Techniques, Research
D002230 Carbidopa An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself. Methyldopahydrazine,Carbidopa, (R)-Isomer,Carbidopa, (S)-Isomer,Lodosin,Lodosyn,MK-485,MK-486,MK 485,MK 486,MK485,MK486
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
June 2019, Hormones (Athens, Greece),
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
May 2005, Hospital medicine (London, England : 1998),
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
January 1995, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
January 1978, Psychopharmacology bulletin,
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
January 1986, Progress in brain research,
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
December 1978, British journal of clinical pharmacology,
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
July 1977, The American journal of psychiatry,
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
April 1964, Mental hygiene,
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
August 1978, The American journal of psychiatry,
B M Davis, and K L Davis, and R C Mohs, and A A Mathé, and A B Rothpearl, and C A Johns, and M I Levy, and T B Horvath
August 1991, Biological psychiatry,
Copied contents to your clipboard!